Emotional distress may motivate patients to undergo prostate cancer surgery unnecessarily
the ONA take:
According to new analyses of a study published in the journal Psychooncology, researchers from the University at Buffalo and Roswell Park Cancer Institute in Buffalo, New York, have found emotionally distressed men diagnosed with prostate cancer may be more likely to opt for surgery.
For the study, researchers assessed 1,050 men diagnosed with clinically localized prostate cancer.
"Importantly, greater distress was associated with choosing more aggressive treatment in men with lower-risk disease among those with potentially low-risk cancer," said Heather Orom, PhD, lead investigator and an assistant professor of community health in University at Buffalo's School of Public Health and Health Professions. "These are men for whom active surveillance may be a viable option."
The initial study showed that lack of confidence in treatment decisions, worry over cancer progression, feelings of threatened masculinity, and tendencies of less optimism and resilience were associated with greater distress in newly diagnosed patients with prostate cancer.
Emotionally distressed men diagnosed with prostate cancer may be more likely to opt for surgery.
- Physical Activity Improves Outcomes for Patients with Breast Cancer and Survivors
- Behavior Pain Assessment Tool Measures Pain In Patients Who Cannot Communicate Verbally
- Whole Genome Sequencing Reveals that 12% of Childhood Cancer Survivors Have Mutations in Genes that Increase Cancer Risk
- Novel Test For Multiple Myeloma Uses Microchip, Conventional Blood Sample
- Increased 5-Year Survival Rate Seen in NSCLC Subset Treated With Nivolumab
- Exercise, Psychological Interventions Better for Cancer Fatigue Than Medications
- ASCO Issues Global Guidance for HPV Vaccination for Cervical Cancer Prevention
- Discharge Events Improved With Standardized Inpatient Palliative Care Consultation
- Little Opposition to Early Palliative Care for Symptom Management in Pediatric Oncology
- Updated ASTRO Guideline Bolsters Safety, Efficacy of Palliative RT for Bone Metastases
- Thyroid Cancer Incidence Increasing Among Younger, Hispanic, African American Populations
- JAK1, JAK2 Inhibition Improves Outcomes in Myeloproliferative Neoplasms, But More Is Needed
- Recommendations Against Contralateral Prophylactic Mastectomy Not Tied to Patient Satisfaction
- Self-efficacy Level Predictive of Likelihood to Follow Through With Colorectal Cancer Screening
- Chronic Myeloproliferative Neoplasms Treatment (Fact Sheet)
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|